Cargando…
ANKRD22 is involved in the progression of prostate cancer
Prostate cancer is a common malignant tumor in elderly men. As a novel metabolic-reprogramming molecule, the role of ankyrin repeat domain 22 (ANKRD22) in the tumorigenesis and progression of prostate cancer remains unknown. In the present study, mouse monoclonal antibodies against human ANKRD22 wer...
Autores principales: | Qiu, Yiqing, Yang, Saisai, Pan, Tianhui, Yu, Lin, Liu, Jingwen, Zhu, Yongliang, Wang, Hongping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732940/ https://www.ncbi.nlm.nih.gov/pubmed/31516611 http://dx.doi.org/10.3892/ol.2019.10738 |
Ejemplares similares
-
ANKRD22, a novel tumor microenvironment-induced mitochondrial protein promotes metabolic reprogramming of colorectal cancer cells
por: Pan, Tianhui, et al.
Publicado: (2020) -
ANKRD22 Drives Rapid Proliferation of Lgr5(+) Cells and Acts as a Promising Therapeutic Target in Gastric Mucosal Injury
por: Liu, Jingwen, et al.
Publicado: (2021) -
ANKRD22 is a potential novel target for reversing the immunosuppressive effects of PMN-MDSCs in ovarian cancer
por: Chen, Huanhuan, et al.
Publicado: (2023) -
ANKRD22 promotes progression of non-small cell lung cancer through transcriptional up-regulation of E2F1
por: Yin, Jun, et al.
Publicado: (2017) -
KBG syndrome involving a single-nucleotide duplication in ANKRD11
por: Kleyner, Robert, et al.
Publicado: (2016)